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Abstract. 
 
Endochondral ossiﬁcation begins from the
condensation and differentiation of mesenchymal cells
into cartilage. The cartilage then goes through a pro-
gram of cell proliferation, hypertrophic differentiation,
calciﬁcation, apoptosis, and eventually is replaced by
bone. Unlike most cartilage, articular cartilage is ar-
rested before terminal hypertrophic differentiation. In
this study, we showed that TGF-
 
b
 
/Smad3 signals inhibit
terminal hypertrophic differentiation of chondrocyte
and are essential for maintaining articular cartilage.
Mutant mice homozygous for a targeted disruption of
 
Smad3 exon 8 (
 
Smad3
 
ex8/ex8
 
) developed degenerative
joint disease resembling human osteoarthritis, as char-
acterized by progressive loss of articular cartilage, for-
mation of large osteophytes, decreased production of
proteoglycans, and abnormally increased number of
type X collagen–expressing chondrocytes in synovial
joints. Enhanced terminal differentiation of epiphyseal
growth plate chondrocytes was also observed in mutant
mice shortly after weaning. In an in vitro embryonic
metatarsal rudiment culture system, we found that
TGF-
 
b
 
1 signiﬁcantly inhibits chondrocyte differentia-
tion of wild-type metatarsal rudiments. However, this
inhibition is diminished in metatarsal bones isolated
 
from 
 
Smad3
 
ex8/ex8
 
 mice. These data suggest that TGF-
 
b
 
/
Smad3 signals are essential for repressing articular
chondrocyte differentiation. Without these inhibition
signals, chondrocytes break quiescent state and un-
dergo abnormal terminal differentiation, ultimately
leading to osteoarthritis.
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b
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Introduction
 
Osteoarthritis is the most common noninflammatory
 
disease of synovial joints, which is distinct from rheumatoid
arthritis, a systemic autoimmune disorder (Fujita, 1997;
Simon, 1999; van den Berg, 1999; Goldring, 2000). Os-
teoarthritis is characterized by the progressive loss of articu-
lar cartilage, resulting in pain and loss of joint function. This
 
condition affects a majority of people 
 
.
 
75 yr of age, and the
underlying mechanism is largely unknown.
Bone is formed through intramembranous and endo-
 
chondral ossification (Erlebacher et al., 1995). Endochondral
ossification initiates by the condensation and differentiation
 
of mesenchymal cells into cartilage. The cartilage then pro-
ceeds through programmed cell proliferation, maturation,
hypertrophic differentiation, calcification, apoptosis, and
eventual replacement by bone tissues. Bone is continuously
renewed by a process of bone remodeling that consists of
cycles of bone formation and resorption. Unlike most carti-
lage, the articular cartilage is arrested before terminal hy-
pertrophic differentiation and forms a smooth cartilage
layer that covers the heads of bone and enables frictionless
and pain-free movement of the joint.
 
Several members of the TGF-
 
b
 
 super family play
important roles in bone growth. The bone morphoge-
 
netic proteins (BMPs)
 
1
 
 induce early cartilage formation
(Wozney, 1989, 1992) and stimulate mesenchymal cells to
differentiate into osteoblasts (Vukicevic et al., 1989;
Yamaguchi et al., 1991; Wozney, 1992). Mice harboring
 
mutations in members of the TGF-
 
b
 
 super family display
multiple skeletal defects (Kingsley et al., 1992; Luo et al.,
1995; Mikic et al., 1995; Storm and Kingsley, 1996; Kata-
giri et al., 1998; Solloway et al., 1998; Ducy and Karsenty,
2000). TGF-
 
b
 
s and their receptors are expressed during
the development of the skeleton and play important roles
in regulating chondrocyte proliferation and differentia-
tion (Sandberg et al., 1988; Gatherer et al., 1990; Pelton et
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al., 1990; Millan et al., 1991; DiLeone et al., 1997; Fuku-
mura et al., 1998; Horner et al., 1998; Kabasawa et al.,
1998). It was shown that TGF-
 
b
 
s can stimulate cultured
undifferentiated mesenchymal cells to differentiate into
chondrocytes (Kulyk et al., 1989; Lafeber et al., 1993; Den-
ker et al., 1995). Injection of TGF-
 
b
 
s in the periosteum of
rat (Joyce et al., 1990) or mouse (Chimal-Monroy and
Diaz de Leon, 1997) femur induces chondrocyte differenti-
ation and cartilage formation. On the other hand, TGF-
 
b
 
s
can also inhibit hypertrophic differentiation of cultured
chondrocyte and metatarsal bones (Ballock et al., 1993;
Tschan et al., 1993; Dieudonne et al., 1994; Bohme et al.,
1995). Notably, expression of dominant negative type II
TGF-
 
b
 
 receptors in cartilage and the synovium transgenic
mice altered chondrocyte differentiation and resulted in
phenotypes sharing some similarities with human osteoar-
thritis (Serra et al., 1997). Altogether, these studies indi-
cate that TGF-
 
b
 
 signals function as key regulators in bone
formation, remodeling, and maintenance.
TGF-
 
b
 
s signals are transduced into nuclei by intracellu-
lar mediator SMADs (Heldin et al., 1997; Massague, 1998;
Datto and Wang, 2000). At least eight different SMADs
have been found in mammals so far. Based on their func-
tions, these SMADs are categorized into three types: the
receptor-activated SMADs, the common mediator SMAD
(SMAD4), and the inhibitory SMADs (SMAD6 and 7).
The receptor-activated SMADs include SMADs 1, 2, 3, 5,
and 8. SMADs 2 and 3 respond to TGF-
 
b
 
 and activins (Ep-
pert et al., 1996; Graff et al., 1996; Macias-Silva et al., 1996;
Zhang et al., 1996; Nakao et al., 1997), whereas SMAD1, 5,
and 8 function in BMP signaling pathways (Lagna et al.,
1996; Liu et al., 1996; Kretzschmar et al., 1997; Suzuki et
al., 1997; Kawabata et al., 1998; Nakayama et al., 1998).
Mutational analysis in mice using gene targeting has re-
vealed multiple important functions for these genes in de-
velopment (for review see Weinstein et al., 2000). Loss of
Smad3 function results in diminished T cell response to
TGF-
 
b
 
 (Datto et al., 1999; Yang et al., 1999), accelerated
wound healing (Ashcroft et al., 1999), and colon carcinoma
(Zhu et al., 1998). Although 50–70% of 
 
Smad3
 
ex8/ex8
 
 mice
die 3 mo after birth due to infections adjacent to the mu-
cosal surface, the remaining mutant mice overcome the in-
fection and survive 
 
#
 
10 mo (Yang et al., 1999). We now
show that the 
 
Smad3
 
ex8/ex8
 
 mice display skeletal abnormali-
ties shortly after weaning, which become worse as the mice
aged. One of the major characteristics of these mice is ab-
normal hypertrophic differentiation of articular chondro-
cytes, leading to the progressive loss of articular cartilage
and formation of large osteophytes in synovial joints. Our
further analysis indicates that Smad3-mediated signals are
essential for cartilage maintenance rather than its forma-
tion. Loss of chondrocyte responsiveness to TGF-
 
b 
 
signals
during chondrogenesis in the 
 
Smad3
 
ex8/ex8
 
 mice results
in abnormal chondrocyte terminal differentiation, which
causes progressive degenerative cartilage disease resem-
bling osteoarthritis in human.
 
Materials and Methods
 
X-Ray Imaging and Skeleton Preparation
 
Smad3
 
ex8/ex8
 
 mice (Yang et al., 1999) were killed by CO
 
2
 
. The skin and the
viscera were removed. Photographs were taken in an x-ray machine (Fax-
itron X-ray, Co.). Preparation of whole mice skeletons was carried out us-
 
ing standard procedures (McLeod, 1980). In brief, the mice without skin
and viscera were fixed in 95% ethanol for 72 h and transferred into ace-
tone for 48 h to remove fat and solidify the skeleton. After alcian blue and
alizarin red S staining for 3 d, the samples were washed in distilled water
and cleaned in 1% KOH and then processed through a series of 20, 50,
and 80% glycerine/1% KOH solutions.
 
The Histologic and Immunohistologic Analysis of 
the Skeletal Tissues
 
The knee joints were fixed in 4% paraformaldehyde at 4
 
8
 
C overnight and
decalcified in 0.5 M EDTA/PBS. Decalcified tissues were dehydrated and
embedded in wax using standard procedures. The polyclonal antibody
against type X collagen was provided by Bjorn Olsen (Harvard Medical
School, Boston, MA). Zymed Laboratories Kit was used for immunohis-
tologic staining.
To detect the expression of the proteoglycan in the skeletal tissues, saf-
ranine O staining was performed on slides. The slides were stained in he-
matoxylin for 1 min and destained in HCL/ethanol and NH
 
4
 
OH/ethanol
solutions. The slides were then rinsed quickly in 1% acetic acid after stain-
ing in 0.2% Fast green for 2 min. After rinsing in distilled water, the slides
were further stained in 0.1% safranine O for 5 min. Finally, the slides were
dehydrated and mounted using standard procedures.
 
In Situ Hybridization
 
In situ hybridization was carried out using standard procedures. Probes
used were Smad2 (Weinstein et al., 1998), Smad3 (Yang et al., 1999), FGF
receptor (FGFR)3 (Deng et al., 1996), and others (see acknowledgments).
Slides were dipped in emulsion (NTB-2; Eastman Kodak Co.) and ex-
posed for 7–15 d before developing.
 
Embryonic Metatarsal Rudiment In Vitro Culture
 
Metatarsal rudiments were isolated from 17.5 pc pregnant 
 
Smad3
 
1
 
/ex8
 
 fe-
male mice that were mated with 
 
Smad3
 
1
 
/ex8
 
 male mice. The three left–
right paired central bones were used in experiments. Rudiments were cul-
tured in 24-well plates with 350 
 
m
 
l BGJb medium (Cat. 12591–038;
GIBCO BRL) supplemented with 0.05 mg/ml ascorbic acid (Sigma-
Aldrich), 0.5 mg/ml 
 
L
 
-glutamine, 10 mg/ml streptomycin, 10 units/ml peni-
cillin (Cat. 11679; GIBCO BRL), 1 mM 
 
b
 
-glycerophosphate (Sigma-
Aldrich), and 0.2% faction V BSA (A-9647; Sigma-Aldrich). Explants
were grown at 37
 
8
 
C in a humidified 5% CO
 
2
 
 incubator. TGF-
 
b
 
1 (10 ng/ml)
(240-B; R&D Systems) in 4 mM HCL was added to cultures 16–20 h after
dissection. Medium was changed on the second day of culture. The rudi-
ments were observed and photographed under a dissecting microscope
(Leica) at 0, 2, and 4 d of treatment. The total length (TL) and the hyper-
trophic length (HL) of chondrocyte, which includes the zone of mineral-
ized chondrocytes and the light regions flanking it, were measured with an
eyepiece scale. Changes in length were expressed as percentage increase
relative to the value before the treatment (percentage increase 
 
5
 
 [length at
day 4 
 
2 
 
length at day 0]/length at day 0). Data are expressed as mean 
 
6
 
SD, and the significance of differences was evaluated with Student’s 
 
t
 
 test.
 
Results
 
Skeletal Defects of the Smad3
 
ex8/ex8
 
 Mice
 
To study function of Smad3 in skeletal formation and de-
velopment, we examined 
 
Smad3
 
ex8/ex8
 
 
 
mice created previ-
ously (Yang et al., 1999). Our data showed that these mice
were often kyphotic (abnormal rearward curvature of the
spine) and moved with difficulties. Using x-ray radio-
graphic analysis, kyphoscoliosis and abnormal calcification
of the synovial joints was observed in the 
 
Smad3
 
ex8/ex8
 
 mice
 
.
 
6 mo of age (Fig. 1 B). The knee joints were usually en-
larged due to osteophytes (extra cartilage and bones) that
had developed at the joint margins and within the joint
space (Fig. 1 D). The osteophytes were also observed in
vertebral bone joints (Fig. 1 F) and sternum joints (Fig. 1
H). As the mutant mice aged, the clinical signs were get-
ting progressively worse and eventually resulted in loss of
movement. No similar abnormalities were seen in age- 
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matched wild-type and heterozygous controls (Fig. 1, A,
C, E, and G).
Next, we examined alizarin red and alcian blue whole
mount skeletal preparations of mice at ages from postnatal
day (P)1, P21, P30, and 4 and 6 mo to determine the onset
of skeletal abnormalities. 
 
Smad3
 
ex8/ex8
 
 mice at 
 
#
 
1 mo of
age did not show any apparent abnormalities in synovial
joints or rib cages compared with their wild-type and het-
erozygous littermates (Fig. 2, A, C, and D). In contrast, all
older 
 
Smad3
 
ex8/ex8
 
 mice exhibited varying abnormalities in
rib cages characterized by the accumulation of bony mate-
rials (Fig. 2, E–G). As the mutant mice aged, the symp-
toms were getting progressively stronger and became ob-
vious in all mutant mice examined at ages 
 
$
 
6 mo of age
(
 
n
 
 
 
5
 
 10). Osteophytes were also detected in other joints
(Fig. 2 B; data not shown). The ribs of mutant mice were
 
severely distorted due to abnormal ossification (Fig. 2 G).
Because these abnormalities were not found in younger
mice and they become progressively worsen in aging pop-
ulation, we conclude that Smad3 plays an important role in
maintaining skeletal integrity rather than in its formation.
Although the majority of bones in younger mice were
normal, we found that 
 
z
 
30% of the 
 
Smad3
 
ex8/ex8
 
 mice ex-
hibited unilateral or bilateral angular distortion in their
forelimbs due to abnormal formation in tarsal bones (Fig.
2 I). Since this defect is seen in P1 mice and does not show
progressive nature compared with the degenerative skele-
tal defects found in older mice, it may therefore represent
a patterning defect in embryonic skeletal development
caused by the Smad3 deficiency. The mechanism underly-
ing this defect is currently unknown and will be addressed
in future studies.
Figure 1. Radiographs of the skeletal abnormali-
ties in 7-mo-old Smad3ex8/ex8 mice. (A and B)
Whole-mount view of control and mutant skele-
tons. Mutant mice exhibited increased intensities in
vertebral and knee joints (arrowheads). (C–H) En-
larged views of knee (C and D), vertebral (E and
F), and sternum joints (G and H). The increased
density in mutant joints is caused by formation of
extra bones (arrowheads). However, decreased
bone densities were found in other areas of mutant
bones compared with corresponding regions of
control mice (arrows). 
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Histologic Analysis of Skeletal Tissues of the 
Smad3
 
ex8/ex8
 
 Mice
 
To characterize the degenerative abnormalities in
 
Smad3
 
ex8/ex8
 
 mice in more detail, synovial joints were sec-
tioned for histologic analysis. There were no apparent dif-
ferences in bone mass between 
 
Smad3
 
ex8/ex8
 
 and control
mice 
 
z
 
30 d of age as revealed by x-ray and whole mount
skeletal preparation (Fig. 2, A and C; data not shown).
However, an abnormal increase in the number of hyper-
trophic chondrocytes was seen in the articular cartilage of
mutant mice at this stage (Fig. 3 B), whereas the majority
of articular cartilage cells in the control mice remained as
resting chondrocytes (Fig. 3 A). The histology of knee
joints from mutant mice at 4 mo of age revealed progres-
sive loss of the smooth surface of articular cartilage. The
articular surface of mutant joints with mild degeneration
was covered with abnormally differentiated chondrocytes
(Fig. 3 D) instead of a thin layer of resting chondrocytes
found in control mice (Fig. 3 C). Surface fibrillation (verti-
cal cleft development) and osteophytes with varying sizes
were seen in the synovial cavities of most 6-mo-old mutant
mice (Fig. 3, F and G). Although these osteophytes were
positive for type II collagen (Fig. 3 H), a marker for chon-
drocytes, type I collagen, and osteocalcin markers for os-
teoblast cells were also detected (Fig. 3, I and J), revealing
the presence of both chondrocytes and osteoblasts in the
outgrowth of endochondral tissues. Similar abnormalities
were also detected in vertebral joints of mutant mice (data
 
not shown). These observations indicate that Smad3 defi-
ciency does not interfere with synovial joint formation;
however, it causes progressive articular cartilage degener-
ation resembling osteoarthritis in humans.
 
Increased Hypertrophic Differentiation of Epiphyseal 
Growth Plate Chondrocytes in Smad3
 
ex8/ex8
 
 Mice
 
We next examined the epiphyseal growth plates to deter-
mine if Smad3 deficiency could cause similar defects.
Chondrocytes in wild-type growth plates can be divided
into four different cell types: resting, proliferating, matur-
ing, and hypertrophic chondrocytes (Fig. 4, A and B). Ex-
amination of mutant mice at multiple early developmental
stages, including P1, P9, and P12, did not reveal obvious
abnormalities compared with their littermate controls (Fig.
4, A and B). This observation indicates that loss of Smad3
does not interfere with chondrogenesis at these develop-
mental stages. However, the height of the hypertrophic
zone gradually increased in some 3–4-wk-old 
 
Smad3
 
ex8/ex8
 
mice
 
 
 
(Fig. 4, C and D, arrows).
 
 
 
This phenotype became
more obvious in 6–8-wk-old mutant mice (Fig. 4, E–H).
This observation suggests that the Smad3 deficiency
caused increased hypertrophic differentiation of mutant
growth plate chondrocytes. Furthermore, growth plates of
P21 or older mutant animals also contained fewer prolifer-
ating chondrocytes than their controls (Fig. 4, C–H). In this
case, mutant chondrocyte columns were not only shorter
but also were arranged irregularly (Fig. 4, C–F, arrows),
Figure 2. Abnormal skeletal develop-
ment in Smad3ex8/ex8 mice. (A and B)
Alizarin red S and Alcian blue staining
of hindlimbs of P21 (A) and 7-mo-old
(B) mice. Genotypes as indicated. (C–H)
Rib cages of P21 (C and D), 5- (E and F),
and 7-mo-old (G and H) mice. F is an
enlarged view of E showing accumula-
tion of bony material in sternum joints.
Arrows point to abnormally formed
bones of mutant mice. (I and J) Angu-
lar defects of tarsal bones in P21 mouse. 
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suggesting that Smad3-mediated signals also play a role in
chondrocyte proliferation. Because the defects were not
observed in younger mice, we suggest that
 
 
 
Smad3 is re-
quired for maintenance, rather than formation of the epi-
physeal growth plate. Similar abnormalities were also de-
tected in vertebrae and sternum (data not shown).
 
Increased Expression of Type X Collagen and 
Decreased Proteoglycan Content in Smad3
 
ex8/ex8
 
 Mice
 
To characterize the skeletal abnormalities of 
 
Smad3
 
ex8/ex8
 
mutant mice at molecular level, we checked the expression
of type X collagen, a marker of chondrocyte differentiation.
More intense type X collagen staining was found in the
 
Smad3
 
ex8/ex8
 
 growth plate (Fig. 5 B) and articular cartilage
(Fig. 5 D), as compared with controls (Fig. 5, A and C). The
type X staining also marked the osteophytes (Fig. 5 E).
Abnormal differentiation of articular cartilage may lead
to changes of matrix components. Therefore, we examined
expression of proteoglycans, a class of matrix proteins that
are produced by chondrocytes and interact with hyal-
uronic acid, link proteins, and collagen fibers. No apparent
differences in safranine O, which stains proteoglycans,
were found in P12 mutant and control mice (Fig. 6, A and
B). However, P40 
 
Smad3
 
ex8/ex8
 
 
 
mice showed significantly
reduced safranine O staining in both the articular cartilage
and growth plate compared with wild-type mice (Fig. 6, C
and D). Decreased safranine O staining was often found in
articular joint of 6-mo-old 
 
Smad3
 
ex8/ex8
 
 
 
mice as more carti-
Figure 3. Histologic analysis of articular cartilage
of  Smad3ex8/ex8 mice. (A and B) Knee joints of
P30 wild-type (A) and mutant (B) mice. Notice
the increased number of hypertrophic chondro-
cytes in mutant articular cartilage. (C–F) Knee
joints of 4- (C and D) and 7-mo-old (E and F)
wild-type (C and E) and mutant (D and F) mice.
Arrow points to abnormally accumulated layer of
chondrocytes (D). (G–J) Osteophytes found in
synovium of 7-mo-old mice. Arrows point to os-
teophytes, hematoxylin and eosin (G), collagen
type II (H), collagen type I (I), and osteocalcin
(J) expression in osteophytes. Bar: (A and B) 150
mm; (C–J) 100 mm. 
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lage turned into bone (Fig. 6, E–H). Small regions of en-
hanced safranine O staining were also observed in some
abnormal outgrowths of the articular cavity (not shown),
indicating fibrocartilaginous repair occurred. These results
suggest that the lack of Smad3-mediated TGF-
 
b
 
 signals
promotes the terminal differentiation of articular cartilage
and may affect the rate of cartilage matrix turnover, even-
tually leading to articular cartilage degeneration.
 
Expression of Smad3, FGFR3, and Indian Hedgehog in 
Skeletal Tissues
 
Previous studies showed that Smad3 is expressed in multiple
organs and/or tissues (Yang et al., 1999). Smad3 protein is
 
also detected in the maturing zone of rat epiphyseal growth
plates at a level higher than other zones (Sakou et al., 1999).
However, its expression in the mouse articular cartilage and
synovium has not been studied. Therefore, we checked ex-
pression of Smad3 during endochondral ossification in the
rib cage and knee joints using in situ hybridization. Our data
showed that Smad3 is expressed in the perichondrium of the
ribs and the sternebrae joints with higher levels (Fig. 7,
A–C). Smad3 transcripts were also detected in articular car-
tilage and trabecular bones (Fig. 7, D–F). This expression
pattern correlates with sites of abnormalities found in the
 
Smad3
 
ex8/ex8
 
 mice, suggesting that loss of Smad3 signals in
 
Smad3
 
ex8/ex8
 
 mice could be primary for these defects.
Figure 4. Histologic analysis of epiphyseal
growth plates of Smad3ex8/ex8 mice. (A and
B) Sections of wild-type (A) and mutant (B)
growth plates from P12 tibiae. Chondro-
cytes are divided into four distinct zones:
resting (Rc), proliferation (Pc), maturing
(Mc), and hypertrophic (Hc) chondrocytes.
No apparent difference was detected. (C–H)
Sections of wild-type (C, E, and G) and mu-
tant (D, F, and H) growth plates isolated
from P21, (C and D), P40 (E and F), and
P60 (G and H) mice. Arrows in C and D
point to hypertrophic chondrocytes positive
for type X collagen. Arrows in E and H
point to chondrocyte columns. Tb, trabecu-
lar bone. Bar: (A, B, G, and H) 80 mm; (C,
D, E, and F) 120 mm. 
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Notably, expression pattern of Smad3 overlaps with that
of several growth factors and signaling molecules, includ-
ing Indian hedgehog (Ihh) and FGFR3, both of which are
important for long bone growth (Deng et al., 1996; Chen et
al., 1999; Li et al., 1999; St-Jacques et al., 1999; Iwata et al.,
2000). In situ hybridization analysis revealed no significant
change of Ihh (Fig. 7, G and H). However, FGFR3 expres-
sion in proliferating chondrocytes was slightly decreased
(Fig. 7, I and J, arrows), whereas no change in the matur-
ing zone of chondrocytes was detected. This observation
suggests that Smad3 signals may regulate FGFR3 expres-
sion in chondrocytes. However, the significance of this
regulation is currently unknown and should be addressed
in future studies. Next, we checked expression of Smad2,
which shares a transduction pathway with Smad3 in medi-
ating TGF-
 
b
 
 and activin signals. Our data showed that
Smad2 expression in wild-type growth plates is similar to
Smad3 (data not shown). We detected no change in ex-
pression of Smad2 in Smad3ex8/ex8 chondrocytes, indicating
that the loss of Smad3 did not cause a complementary al-
teration of this highly related gene.
Diminished Response of Smad3ex8/ex8 Bone Rudiment to 
TGF-b1 Inhibition
Previous studies have shown that TGF-b1 can inhibit both
chondrocyte proliferation and hypertrophic differentia-
tion (Ballock et al., 1993; Tschan et al., 1993; Bohme et al.,
1995; Serra et al., 1997). TGF-b1, 2, 3 and their receptors
are expressed in the perichondrium, articular cartilage,
and growth plate chondrocytes (Fukumura et al., 1998;
Horner et al., 1998; Kabasawa et al., 1998; Sakou et al.,
1999) where Smad3 is expressed. It is conceivable that the
diminished chondrocyte response to TGF-b at these sites
is a primary cause for the observed abnormalities. To test
this, we used an in vitro embryonic bone culture system
where bone growth could be maintained in defined condi-
tions to monitor chondrocyte proliferation and differentia-
tion. For these experiments, we cultured embryonic meta-
tarsals from E17.5 mice. Bone rudiments at this stage have
already initiated endochondral ossification as illustrated in
Fig. 8 A. Bone growth was determined by increased whole
bone length and hypertrophic zone expansion toward the
rudiments’ ends 4 d after culture (Fig. 8, A and B). In the
presence of TGF-b1 (10 ng/ml), however, the expansion of
hypertrophic zone was repressed in comparison to un-
treated controls (Fig. 8, B and F). Quantitative measure-
ment of nine pairs of cultured bones indicated that the av-
erage length of hypertrophic zones (HLs) of the treated
bones is z70% that of wild-type bones (Fig. 8 M). In the
histologic sections, bones treated with TGF-b1 exhibited a
narrower region containing hypertrophic chondrocytes of
smaller sizes (Fig. 8 K, arrow) compared with correspond-
ing region in untreated controls (Fig. 8 I). These observa-
tions indicate that TGF-b1 significantly inhibits chondro-
cyte differentiation.
We then examined bones isolated from Smad3ex8/ex8 mice.
Without TGF-b1, there is no significant difference between
mutant and wild-type bones (Fig. 8, B and D). This is con-
sistent with our observation that Smad3 mutation does not
affect bone growth at early stages. Notably, the TGF-b1
treatment could not repress the expansion of the hyper-
trophic zone of mutant explants (Fig. 8, D and H, and 8 M
for quantitative comparison). Histologic sections revealed
no apparent morphological changes between treated and
untreated bones (Fig. 8, J and L). These observations indi-
cate that the inhibition of TGF-b1 on chondrocyte hyper-
trophic differentiation is largely Smad3 dependent.
Our data also showed that the TLs of treated bones
were slightly reduced compared with that of the untreated
controls (Fig. 8 M), suggesting that TGF-b1 treatment de-
Figure 5. Immunohistochemical detection of
collagen type X expression in 6-mo-old wild-type
(A and C) and mutant (B, D, and E) mice. A and
B, growth plates; C and D, knee joints; and E, os-
teophyte. F is an image without the first antibody
serving as a negative control. Bar, 100 mm.The Journal of Cell Biology, Volume 153, 2001 42
creased proliferation of chondrocytes in the culture condi-
tions. This function is Smad3 independent since both wild-
type and Smad3 mutant bones showed similar reductions.
Discussion
Osteoarthritis occurs at a very high frequency affecting the
majority of the aging population (Fujita, 1997; Simon,
1999). Although multiple factors have been shown to affect
articular cartilage in osteoarthritis, the molecular mecha-
nism(s) underlying the cartilage degeneration is largely un-
known. In this study, we have investigated a role of TGF-
b/Smad3 signals in bone formation and cartilage develop-
ment in Smad3ex8/ex8 mice generated by gene targeting. We
showed that Smad3 deficiency results in a skeletal condi-
tion that exhibits some features mimicking human osteoar-
thritis, including progressive loss of articular cartilage, for-
mation of large osteophytes, decreased production of
proteoglycan, and abnormally increased number of type X
collagen–expressing chondrocytes in synovial joints. We
further showed that the articular cartilage degeneration in
Smad3ex8/ex8 mice is associated with increased chondrocyte
differentiation, which is normally repressed by TGF-b/
Smad3 signals. Thus, our study establishes an essential role
of Smad3 in maintaining articular cartilage integrity, which
is pivotally important for normal joint functions.
TGF-bs, especially TGF-b1, 2, and 3 and their recep-
tors, have been implicated in osteoarthritis (van den Berg,
1999). When injected into knee joints of mouse or rabbit,
TGF-b1 or 2 can stimulate chondrocyte differentiation
and induce osteophyte formation at sites characteristic for
osteoarthritis (van Beuningen et al., 1994, 2000; van den
Figure 6. Expression of proteoglycans in wild-
type (A, C, E, and G) and mutant (B, D, F, and
H) skeletal tissues. Safranine O staining of epi-
physeal growth plates and articular cartilage of
P12 (A and B), P40 (C and D), and 6-mo-old
(E–H) mice. Arrows point to articular cartilage.
Enlarged images in C and D show hematoxylin
and eosin sections. H, hypertrophic zone; and M,
all other zones including Rc, Pc, and Mc. Bar: (A
and B) 250 mm; (C, D, G, and H) 150 mm; (E and
F) 600 mm.Yang et al. Smad3 Deficiency Results in Osteoarthritis 43
Berg, 1995), suggesting that TGF-bs may serve as patho-
gens for this disease. On the other hand, it was also
showed that TGF-b1 can suppress acute and chronic ar-
thritis in rat, implicating this cytokine as a potentially im-
portant therapeutic agent (Brandes et al., 1991). More-
over, it was shown that expression of a dominant negative
type II TGF-b receptors in cartilage and the synovium al-
tered chondrocyte differentiation and resulted in degener-
ative joint abnormalities resembling human osteoarthritis
(Serra et al., 1997). These seemingly contradictory data
suggest the function of TGF-bs in endochondral ossifica-
tion is complex. Indeed, as multifunctional growth factors,
TGF-bs could exhibit differential effects depending on the
differentiation stage of the target cells. Numerous studies
in multiple model systems have documented that although
TGF-bs stimulate early chondrocyte differentiation, they
inhibit the later stages of cartilage formation, especially
the terminal differentiation of chondrocytes (Seyedin et
al., 1985; Kulyk et al., 1989; Ballock et al., 1993; Lafeber et
al., 1993; Tschan et al., 1993; Dieudonne et al., 1994;
Bohme et al., 1995; Denker et al., 1995; Serra et al., 1999).
Alternatively, it is possible that different doses of TGF-b
could cause a biphasic response in same type of cells by
activating different downstream effectors with opposite
functions.
TGF-b transduces signals from the cell membrane to the
nucleus via specific type I and II receptors and Smad pro-
teins. TGF-b1, 2, and 3 and their receptors are expressed
Figure 7. Analysis of gene expression
by in situ hybridization. (A–F) Smad3
expression in ribs of embryonic day 16
(A–C) and P12 growth plate (D–F) of
wild-type mice. A and D are bright
field view, and B, C, E, and F are dark
field view. B and E are anti-sense, and
C and F are sense controls. Arrow and
arrowhead in E point to perichondrium
and articular cartilage, respectively. (G
and H) Ihh expression in wild-type
(G) and mutant (H) mice. (I and J)
FGFR3 expression in wild-type (I) and
mutant (J) mice. Hc, hypertrophic
chondrocytes. Bar: (A and B) 700 mm;
(D–F) 600 mm; (G–J) 500 mm.The Journal of Cell Biology, Volume 153, 2001 44
in articular cartilage and the epiphyseal growth plate (Fu-
kumura et al., 1998; Horner et al., 1998; Kabasawa et al.,
1998; Sakou et al., 1999). TGF-b/activin–restricted Smads
also expressed epiphyseal growth plate in a partially over-
lapping fashion with Smad2 and 3 strongly expressed in
proliferating chondrocytes and maturing chondrocytes, re-
spectively. Smad4, which serves as a central mediator for
both TGF-bs and BMPs, is broadly expressed in all zones
of epiphyseal growth plate (Sakou et al., 1999). The over-
lapping expressions of TGF-b, receptors, and Smads sug-
gest that TGF-b functions in an autocrine fashion during
endochondral ossification.
This brings an essential question that this study aims to
address, that is, what is the physiological function of
Smad3-mediated TGF-b signals in endochondral ossifica-
tion? The observations that blocking TGF-b signals at ei-
ther receptor (Serra et al., 1997) or intracellular level (this
study) causes increased chondrocyte terminal differentia-
tion and progressive degeneration of articular cartilage in-
dicate that one of the physiological functions of TGF-b/
Smad3 signals must be the inhibition of chondrocyte termi-
nal differentiation. This notion is strongly supported by our
in vitro rudiment culture experiments, where TGF-b1
treatment dramatically inhibited chondrocyte hypertrophy
in wild-type but not in Smad3ex8/ex8 bones. These observa-
tions indicate that the inhibition of TGF-b1 on chondrocyte
differentiation is largely Smad3 dependent. Thus, lacking
TGF-b1/Smad3 signals, chondrocytes undergo abnormal
differentiation, which eventually leads to osteoarthritis.
Because TGF-b has been known as a cartilage inducer
and can stimulate cartilage formation both in vitro and in
vivo (Kulyk et al., 1989; Joyce et al., 1990; Lafeber et al.,
1993; Denker et al., 1995; Chimal-Monroy and Diaz de
Leon, 1997), we carefully examined Smad3ex8/ex8 mice to
see if blocking TGF-b responsiveness could affect early
stages of chondrogenesis. Our examinations at multiple
developmental stages detected no developmental defects
in synovial joints and epiphyseal growth plate formation,
suggesting that Smad3 is dispensable in the early stages of
cartilage formation. In histologic sections, we found that
the increased hypertrophic differentiation of chondrocytes
started when animals were z1 mo of age. This leads to the
progressive loss of articular cartilage and formation of os-
teophytes in synovial joints of older mutant mice. Of note,
the severity of cartilage degeneration correlates well with
expression levels of Smad3. Sternebrae joints, where
Smad3 is expressed at a particularly higher level, showed
most severe phenotype (Fig. 2, E–G, and Fig. 7 B).
Cartilage degeneration associated with osteoarthritis is
also linked to aberrant cytokine and growth factor expres-
sion in affected tissues. One of the best studied factors so
far is IL-1, which stimulates chondrocytes to release de-
structive proteases and at the same time, represses pro-
teoglycan synthesis (Beekman et al., 1998; Hui et al., 1998;
Cawston et al., 1999; Flannery et al., 1999; Sandy et al.,
1999). Thus, the combined effect of IL-1 action is reduced
matrix production and enhanced cartilage degradation.
However, the osteoarthritis in Smad3ex8/ex8 mice is distinct
from that caused by IL-1 overexpression. It shows no sign
of enzymatic bone destruction rather than the abnormally
increased bone production in synovial joints at the ex-
pense of increased chondrocyte differentiation, which
starts shortly after weaning.
Another feature exhibited by Smad3ex8/ex8 articular carti-
lage is significantly reduced levels of proteoglycan. This
observation is consistent with previous reports that syn-
thesis of proteoglycan can be stimulated by TGF-b both in
vitro and in vivo (Lafeber et al., 1993; Redini et al., 1997;
Figure 8. Effects of TGF-b1 treatment on cultured wild-type (A,
B, E, F, I, and K) and Smad3 mutant (C, D, G, H, J, and L) embry-
onic (E17.5) metatarsal bones. (ML) The length of the mineralized
hypertrophic chondrocytes (dark area). The light areas flanking
the length of the mineralized hypertrophic chondrocytes (ML) are
the nonmineralized hypertrophic chondrocytes. The regions out-
side the light zones are proliferating chondrocytes. Hypertrophic
zone (HL) includes both mineralized and unmineralized hyper-
trophic zones. TL, total bone length. (I–L) Histologic sections of
wild-type and mutant bones cultured for 4 d in the absence (I
and J) and presence (K and L) of TGF-b1. The arrow in K
points to a region containing hypertrophic chondrocytes with
smaller sizes. (M) Percentage increases in TL and HL of wild-
type and mutant bones cultured for 4 d in the absence (0 ng/ml)
or presence of TGF-b1 (10 ng/ml). WT, wild type; MT, mutant
bones. (Percentage increase 5 [day 4 length 2 day 0 length]/day
0 length). Data represent mean 6 SD of values obtained from
nine pairs of bones.Yang et al. Smad3 Deficiency Results in Osteoarthritis 45
Moller et al., 2000). The reduced proteoglycan production
may significantly contribute to osteoarthritis since it may
lead to further changes in the components of cartilage ma-
trix and the rate of matrix turnover in Smad3ex8/ex8 mice.
Interestingly, the decreased levels of proteoglycans associ-
ated with Smad3 deficiency is similar to that caused by the
IL-1 overexpression (van de Loo et al., 1994, 1998). This
suggests partial overlapping roles between IL-1 and TGF-
b/Smad3 in osteoarthritis initiation and progression.
In summary, we show that Smad3-mediated TGF-b sig-
nals are important for maintaining articular cartilage in
the quiescent state by repressing chondrocyte differen-
tiation and controlling matrix molecule synthesis. Con-
sequently, impairment of TGF-b signals due to Smad3
disruption results in phenotypes resembling human os-
teoarthritis. These mice should serve as an ideal animal
model for performing studies that may eventually lead to
the prevention and effective treatment of osteoarthritis.
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